Scientists have identified a double agent in the eye that, once triggered, can morph from neuron protector to neuron killer. The discovery has significant health implications since the neurons killed through this process results in vision loss and blindness.
The ability of our nervous system to function properly relies on elaborate and precise connections between nerve cells and their targets. In a new study, researchers at The Neuro - The Montreal Neurological Institute and Hospital, McGill University identify a receptor capable of directing and controlling a set of nerve cell projections to their specific target.
Dr. Brenda Milner, an active researcher at the age of 91 at the Montreal Neurological Institute, McGill University, is widely recognized as the founder of cognitive neuroscience–the field that brings together brain and behavior and helps explain key aspects of mental illness. Today, Dr. Milner is being awarded the Goldman-Rakic Prize for Outstanding Achievement in Cognitive Neuroscience by NARSAD,
The biopharmaceutical company Antisense Pharma GmbH has announced today that it has received the approval by Health Canada for its pivotal Phase III clinical trial SAPPHIRE in patients with recurrent or refractory anaplastic astrocytoma.
The repair of damaged nerve cells is a major problem in medicine today. A new study by researchers at the Montreal NeurologicaI Institute and Hospital (The Neuro) and McGill University, is a significant advance towards a solution for neuronal repair.
A new study from the Montreal Neurological Institute and Hospital (The Neuro) of McGill University reveals that different patterns of training and learning lead to different types of memory formation.
World-renowned expert in immunology and genetics, Professor Sir John Bell is coming to Montreal as the guest of the Montreal Neurological Institute and Hospital (The Neuro), McGill University and the Friends of the Canadian Institutes of Health Research (CIHR).
McGill’s new Integrated Program in Neuroscience: All of McGill Neuroscience. Together in One Location.
The Integrated Program in Neuroscience (IPN) is McGill’s brand new, inter-departmental, inter-disciplinary neuroscience program for graduate students. As Canada’s largest training program for neuroscience students, this new program will bring together and encourage synergy amongst faculty members, postdoctoral fellows and students from different backgrounds all with a neuroscience focus.
Dr. Brenda Milner, the Dorothy J. Killam Professor at the Montreal Neurological Institute, McGill University, is one of four recipients of the prestigious International Balzan Prize for 2009. Each awardee will receive approximately $1 million CDN (one million swiss francs), half of which must be designated for research. The announcement was made by the Balzan Foundation Monday in Milan, Italy.
In a new study, researchers at the Montreal Neurological Institute and Hospital (The Neuro), McGill University have found an important mechanism involved in setting up the vast communications network of connections in the brain.
Physicians at The Neuro first in North America to offer a new stent for patients with intracranial aneurysms
A new and advanced technology is now available to patients with large, broad neck intracranial aneurysms. Physicians at the Montreal Neurological Institute and Hospital (The Neuro) at the McGill University Health Centre and McGill University were the first in North America to implant a specialized intracranial stent, providing innovative treatment for intracranial aneurysms.
Sounds and images share a similar neural code in the human brain, according to a new Canadian study. In the online edition of the Proceedings of the National Academy of Sciences (PNAS), scientists from the Université de Montréal and the Montreal Neurological Institute at McGill University explain how the same neural code in the brain allows people to distinguish between different types of sounds,
Researchers at the Montreal Neurological Institute and Hospital (The Neuro), McGill University have discovered a genetic mutation underlying late-onset Leigh syndrome, a rare inherited metabolic disorder characterized by the degeneration of the central nervous system.